0
Skip to Content
Aventa Test
Aventa FusionPlus
Aventa Lymphoma
Ordering
Aventa Assist
Technology
Webinars
About us
News
Events
Contact us
Aventa Test
Aventa FusionPlus
Aventa Lymphoma
Ordering
Aventa Assist
Technology
Webinars
About us
News
Events
Contact us
Folder: Tests
Back
Aventa FusionPlus
Aventa Lymphoma
Ordering
Aventa Assist
Technology
Webinars
Folder: About Us
Back
About us
News
Events
Contact us

Complete characterization of maxillary sinus tumor enables targeted therapy

Nov 5
Written by Erin Davis
Aventa FusionPlus
Erin Davis
Previous
Previous

Actionable NRG1 fusion undetectable by conventional technology

Next
Next

Precise diagnosis of DHL with additional prognostic indicators and possible clinical trial

© Copyright 2026 Arima Genomics

Support is available M-F
9:00 AM – 5:00 PM (ET)
support@aventatest.com

Tel: 1.689.788.4080
Fax: 1.866.960.9960

Aventa Fusion Plus
Aventa Lymphoma
Ordering
Aventa Assist
Technology
Webinars

About us
Contact
Licenses
Privacy Policy

Terms of Use